VX1.DE

Vertex Pharmaceuticals Incorporated [VX1.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VX1.DE Stock Summary

Top 10 Correlated ETFs

VX1.DE


Top 10 Correlated Stocks

VX1.DE


In the News

VX1.DE Financial details

Company Rating
Strong Buy
Market Cap
98.71B
Income
3.62B
Revenue
9.87B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5.4K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
31.39
Forward P/E
22.77
PEG
-16.05
P/S
11.27
P/B
6.6
P/C
-
P/FCF
25.87
Quick Ratio
3.74
Current Ratio
4.08
Debt / Equity
0.05
LT Debt / Equity
0.04
-
-
EPS (TTM)
10.28
EPS next Y
16.91
EPS next Q
-
EPS this Y
9.94%
EPS next Y
64.49%
EPS next 5Y
116.01%
EPS last 5Y
25.13%
Revenue last 5Y
18.84%
Revenue Q/Q
1.38%
EPS Q/Q
-
-
-
-
-
SMA20
-2.9%
SMA50
-2.92%
SMA100
10.28%
Inst Own
-
Inst Trans
-
ROA
16%
ROE
23%
ROC
0.21%
Gross Margin
88%
Oper. Margin
40%
Profit Margin
36%
Payout
-
Shs Outstand
258.31M
Shs Float
257.54M
-
-
-
-
Target Price
-
52W Range
285.05-420.0
52W High
-8.32%
52W Low
+35.11%
RSI
50.95
Rel Volume
0.38
Avg Volume
154
Volume
58
Perf Week
1.78%
Perf Month
-0.79%
Perf Quarter
13.03%
Perf Half Y
16.26%
-
-
-
-
Beta
0.351
-
-
Volatility
2.79%, 7.91%
Prev Close
-0.43%
Price
385.05
Change
0.29%

VX1.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
16.2223.8929.3934.8738.3
Net income per share
4.5810.449.0912.9714.05
Operating cash flow per share
6.1112.5210.2616.1313.73
Free cash flow per share
5.8211.529.3515.3312.72
Cash per share
14.8425.6329.242.0943.53
Book value per share
23.7133.4439.1954.3368.22
Tangible book value per share
16.6926.532.247.7260.74
Share holders equity per share
23.7133.4439.1954.3368.22
Interest debt per share
2.62.632.582.43.31
Market cap
56.56B60.58B57.78B73.85B105.76B
Enterprise value
54.02B55.17B51.54B63.91B96.2B
P/E ratio
48.0622.3424.6722.2329.22
Price to sales ratio
13.599.767.638.2710.72
POCF ratio
36.0418.6221.8617.8829.9
PFCF ratio
37.8620.2323.9918.8132.26
P/B Ratio
9.296.975.725.316.02
PTB ratio
9.296.975.725.316.02
EV to sales
12.988.896.817.169.75
Enterprise value over EBITDA
37.0617.3118.4814.7118.93
EV to operating cash flow
34.4216.9619.515.4727.2
EV to free cash flow
36.1618.4321.416.2829.34
Earnings yield
0.020.040.040.040.03
Free cash flow yield
0.030.050.040.050.03
Debt to equity
0.10.070.060.040.05
Debt to assets
0.070.050.040.030.04
Net debt to EBITDA
-1.74-1.7-2.24-2.29-1.88
Current ratio
3.835.024.815.223.99
Interest coverage
20.4749.1245.2478.686.89
Income quality
1.331.21.131.240.98
Dividend Yield
00000
Payout ratio
0.010000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.420.290.40.280.32
Intangibles to total assets
0.170.120.10.090.08
Capex to operating cash flow
-0.05-0.08-0.09-0.05-0.07
Capex to revenue
-0.02-0.04-0.03-0.02-0.03
Capex to depreciation
-0.71-2.37-1.87-1.38-1.43
Stock based compensation to revenue
0.090.070.060.060.06
Graham number
49.4588.6189.52125.92146.83
ROIC
0.140.250.210.230.16
Return on tangible assets
0.170.260.190.20.17
Graham Net
8.3116.9320.2630.6629.53
Working capital
3.4B6.26B7.14B10.25B10.6B
Tangible asset value
4.68B7.28B8.7B12.22B15.65B
Net current asset value
2.38B4.76B5.68B8.44B8.99B
Invested capital
0.10.070.060.040.05
Average receivables
521.6M759.44M1.01B1.29B1.5B
Average payables
99.3M121.37M175.07M249.45M334.4M
Average inventory
145.93M224.14M316.94M406.85M599.7M
Days sales outstanding
55.5552.0754.7858.9457.82
Days payables outstanding
58.3876.9178.72102.68105.52
Days of inventory on hand
111.62139.19142.54155.62213.64
Receivables turnover
6.577.016.666.196.31
Payables turnover
6.254.754.643.553.46
Inventory turnover
3.272.622.562.351.71
ROE
0.190.310.230.240.21
Capex per share
-0.29-1-0.91-0.8-1

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
8.969.239.679.630
Net income per share
3.192.723.554.010
Operating cash flow per share
4.23.54.44.920
Free cash flow per share
4.073.334.174.760
Cash per share
41.961.343.646.230
Book value per share
54.1656.0760.03640
Tangible book value per share
47.5749.553.4757.450
Share holders equity per share
54.1656.0760.03640
Interest debt per share
2.233.113.022.930
Market cap
74.08B81.58B90.62B90.02B0
Enterprise value
64.14B83.16B92.15B91.51B-9.56B
P/E ratio
22.6229.1424.7421.740
Price to sales ratio
32.1734.3536.3536.250
POCF ratio
68.790.6679.8870.970
PFCF ratio
70.9195.1184.3173.310
P/B Ratio
5.325.655.865.450
PTB ratio
5.325.655.865.450
EV to sales
27.8535.0236.9636.85-3.8
Enterprise value over EBITDA
57.6466.6371.8573.62-8.07
EV to operating cash flow
59.4892.4181.2372.14-40.75
EV to free cash flow
61.3996.9585.7474.53-80.68
Earnings yield
0.010.010.010.010
Free cash flow yield
0.010.010.010.010
Debt to equity
0.040.050.050.050.05
Debt to assets
0.030.040.040.030.04
Net debt to EBITDA
-8.941.261.21.2-8.07
Current ratio
5.224.284.144.083.99
Interest coverage
89.0968.3391.6495.2493.25
Income quality
1.321.291.241.230.24
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.30.310.320.330.33
Intangibles to total assets
0.090.090.080.080.08
Capex to operating cash flow
-0.03-0.05-0.05-0.03-0.49
Capex to revenue
-0.01-0.02-0.02-0.02-0.05
Capex to depreciation
-0.88-1.09-1.44-0.96-1.97
Stock based compensation to revenue
0.050.050.050.050.08
Graham number
62.3258.5669.2876.020
ROIC
0.050.040.050.050.04
Return on tangible assets
0.050.040.050.050.05
Graham Net
30.57-10.7930.3731.830
Working capital
10.25B9.94B10.52B11.1B10.6B
Tangible asset value
12.22B12.74B13.78B14.82B15.65B
Net current asset value
8.44B8.42B8.99B9.48B8.99B
Invested capital
0.040.050.050.050.05
Average receivables
1.41B1.5B1.55B1.55B1.55B
Average payables
215.4M313.55M343.1M369.45M370.4M
Average inventory
424.4M497.85M569.3M646.1M713.75M
Days sales outstanding
56.3758.6656.1855.7655.89
Days payables outstanding
96.54108.98105.87106.1589.24
Days of inventory on hand
146.33180.44176194.49180.68
Receivables turnover
1.61.531.61.611.61
Payables turnover
0.930.830.850.851.01
Inventory turnover
0.620.50.510.460.5
ROE
0.060.050.060.060.06
Capex per share
-0.13-0.16-0.23-0.160

VX1.DE Frequently Asked Questions

What is Vertex Pharmaceuticals Incorporated stock symbol ?

Vertex Pharmaceuticals Incorporated is a US stock , located in Boston of Ma and trading under the symbol VX1.DE

What is Vertex Pharmaceuticals Incorporated stock quote today ?

Vertex Pharmaceuticals Incorporated stock price is $385.05 today.

Is Vertex Pharmaceuticals Incorporated stock public?

Yes, Vertex Pharmaceuticals Incorporated is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks